Regeneron Genetics Center

Presence

Regeneron Genetics Center is owned by Regeneron Pharmaceuticals.


Regeneron Pharmaceuticals is one of the...

Regeneron Pharmaceuticals is a company listed under the stock ticker REGN (US).

They are in:

Acquisition, funding and merger involving Regeneron Pharmaceuticals.

Executives

View the org chart displaying its 7 main executives

Most searched biographies at Regeneron Genetics Center
Popular executive movements at Regeneron Pharmaceuticals
  • Robert Landry, Executive Vice President, Finance and Chief Financial Officer, will retire in Feb. 2024  (posted on September 11 2023).
  • Chris Fenimore who is Senior Vice President and Controller, will be promoted to Chief Financial Officer in Feb. 2024  (posted on September 11 2023).

Create your alert
to follow the executive moves at Regeneron Genetics Center.

News

Press releases by Regeneron Genetics Center
Social media about Regeneron Genetics Center

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.